CRISPR Technologies Addressing Several Therapeutics for Different Cancerous Conditions

CRISPR studies identify many promising therapeutic targets for multiple myeloma New research from Dana-Farber Cancer Institute has identified 116 genes as key molecular vulnerabilities for multiple myeloma. Most of these genes are potential leads for the discovery of new therapies for this disease. The study was published in Nature Cancer. Multiple myeloma is an incurable blood …

Read more »